☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
innovent
Innovent’s IBI343 Gains the US FDA’s Fast Track Designation to Treat Pancreatic Cancer
June 13, 2024
Innovent Reports the P-III (CLEAR-1) Study Data of Picankibart for Treating Plaque Psoriasis in Chinese Patients
May 28, 2024
Innovent Reports the NMPA’s NDA Acceptance of IBI311 for Treating Thyroid Eye Disease
May 21, 2024
Innovent Reports Results from the P-II Study of IBI302 for the Treatment of Neovascular Age-related Macular Degeneration (nAMD)
March 19, 2024
Innovent and AnHeart Therapeutics Report the NMPA’s Acceptance of Second NDA for Taletrectinib to Treat Lung Cancer
March 5, 2024
Innovent Reports Updates on the P-I Evaluation of IBI3002 for the Treatment of Asthma
March 1, 2024
Load more...
Back to Home